Cargando…

Radiosensitization effects of curcumin plus cisplatin on non-small cell lung cancer A549 cells

The aim of the present study was to determine the radiosensitization effect of the combination of curcumin and cisplatin on non-small cell lung cancer (NSCLC) A549 cells. Cell viability was analyzed using the MTT assay following treatment with different concentrations of curcumin and cisplatin for 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Yong, Sheng, Zhaoying, Liang, Shixiong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539728/ https://www.ncbi.nlm.nih.gov/pubmed/31289524 http://dx.doi.org/10.3892/ol.2019.10364

Ejemplares similares

Metformin enhances the radiosensitizing effect of cisplatin in non-small cell lung cancer cell lines with different cisplatin sensitivities
por: Riaz, Muhammad Assad, et al.
Publicado: (2019)

MiR-200c Increases the Radiosensitivity of Non-Small-Cell Lung Cancer Cell Line A549 by Targeting VEGF-VEGFR2 Pathway
por: Shi, Liangliang, et al.
Publicado: (2013)

Enhancement of recombinant myricetin on the radiosensitivity of lung cancer A549 and H1299 cells
por: Zhang, Shijie, et al.
Publicado: (2014)

MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin
por: Li, Weili, et al.
Publicado: (2016)

Radiosensitizing effects of Cyclocarya paliurus polysaccharide on hypoxic A549 and H520 human non-small cell lung carcinoma cells
por: Zhang, Fengmin, et al.
Publicado: (2019)

Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
por: Bian, Hai-Bo, et al.
Publicado: (2011)

Genistein enhances the effect of cisplatin on the inhibition of non-small cell lung cancer A549 cell growth in vitro and in vivo
por: LIU, DEZHI, et al.
Publicado: (2014)

Selective ATP hydrolysis inhibition in F1Fo ATP synthase enhances radiosensitivity in non-small-cell lung cancer cells (A549)
por: Wang, Yupei, et al.
Publicado: (2017)

Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancer
por: Earle, C C, et al.
Publicado: (1999)

Exosomes: Decreased Sensitivity of Lung Cancer A549 Cells to Cisplatin
por: Xiao, Xia, et al.
Publicado: (2014)

The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism
por: Zou, Kun, et al.
Publicado: (2015)

Radiosensitizing Effect of Schinifoline from Zanthoxylum schinifolium Sieb et Zucc on Human Non-Small Cell Lung Cancer A549 Cells: A Preliminary in Vitro Investigation
por: Wang, Cheng-Fang, et al.
Publicado: (2014)

Cisplatin plus vinorelbine as induction treatment in stage IIIA non-small cell lung cancer
por: Palka, Magda, et al.
Publicado: (2017)

Effect of Menadione and Combination of Gemcitabine and Cisplatin on Cancer Stem Cells in Human Non-small Cell Lung Cancer (NSCLC) Cell Line A549
por: Soltanian, Sara, et al.
Publicado: (2021)

Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment
por: Gao, Yanyun, et al.
Publicado: (2019)

Effect of receptor for hyaluronan-mediated motility inhibition on radiosensitivity of lung adenocarcinoma A549 cells
por: Gao, Chunzi, et al.
Publicado: (2019)

Curcumin Increased the Sensitivity of Non-Small-Cell Lung Cancer to Cisplatin through the Endoplasmic Reticulum Stress Pathway
por: Wang, Lile, et al.
Publicado: (2022)

Impact of CHK2-small interfering RNA on CpG ODN7909-enhanced radiosensitivity in lung cancer A549 cells
por: Chen, Wei, et al.
Publicado: (2012)

Nab-Paclitaxel in combination with Cisplatin Versus Docetaxel Plus Cisplatin as First-Line Therapy in Non-small Cell Lung Cancer
por: Chen, Yi, et al.
Publicado: (2017)

MiR-122 Induces Radiosensitization in Non-Small Cell Lung Cancer Cell Line
por: Ma, Debin, et al.
Publicado: (2015)

Synergistic Antitumor Effect of Oligogalacturonides and Cisplatin on Human Lung Cancer A549 Cells
por: Huang, Cian-Song, et al.
Publicado: (2018)

Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer
por: Shimokawa, Tsuneo, et al.
Publicado: (2020)

Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines
por: Schwarz, Katharina, et al.
Publicado: (2020)

Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2
por: Pang, Linrong, et al.
Publicado: (2017)

Inter-assay precision of clonogenic assays for radiosensitivity in cancer cell line A549
por: Nuryadi, Endang, et al.
Publicado: (2018)

RNA-Seq Analysis of Cisplatin and the Monofunctional Platinum(II) Complex, Phenanthriplatin, in A549 Non-Small Cell Lung Cancer and IMR90 Lung Fibroblast Cell Lines
por: Monroe, Jerry D., et al.
Publicado: (2020)

HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells
por: Namwan, Narissara, et al.
Publicado: (2022)

Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer
por: Chen, Xu, et al.
Publicado: (2016)

The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
por: Ye, Ling-Yun, et al.
Publicado: (2017)

Xanthohumol induces apoptosis and S phase cell cycle arrest in A549 non-small cell lung cancer cells
por: Yong, Wai Kuan, et al.
Publicado: (2015)

PRDM14 mediates chemosensitivity and glycolysis in drug-resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells
por: He, Saifei, et al.
Publicado: (2021)

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
por: Stathopoulos, G. P., et al.
Publicado: (2011)

Curcumin induced autophagy anticancer effects on human lung adenocarcinoma cell line A549
por: Liu, Furong, et al.
Publicado: (2017)

Downregulation of HIF-2α Reverse the Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin
por: Gao, Zhao-jia, et al.
Publicado: (2018)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2019)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

Cisplatin radiosensitizes radioresistant human mesenchymal stem cells
por: Rühle, Alexander, et al.
Publicado: (2017)

Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells
por: Minafra, Luigi, et al.
Publicado: (2019)

Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
por: Zhang, Guan-Zhong, et al.
Publicado: (2010)

Radiosensitizers in cervical cancer. Cisplatin and beyond
por: Candelaria, Myrna, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_493h17ne87aen253httbj13ta3